Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

Clinical trial NCT06232239 · UNKNOWN

Trial details

NCT number: NCT06232239
Sponsor: Bio-innova Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-02-27
Primary completion: 2024-04-05
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.